APA (7th ed.) Citation

A, R., L, P., L, P., Z, B., A, O., D, P., . . . M, N. (2026). Association between clinical and pathological factors and risk of radioiodine refractory in patients with differentiated thyroid carcinoma. Frontiers in endocrinology, 17, 1709736. https://doi.org/10.3389/fendo.2026.1709736

Chicago Style (17th ed.) Citation

A, Rakhmankulova, et al. "Association Between Clinical and Pathological Factors and Risk of Radioiodine Refractory in Patients with Differentiated Thyroid Carcinoma." Frontiers in Endocrinology 17 (2026): 1709736. https://doi.org/10.3389/fendo.2026.1709736.

MLA (9th ed.) Citation

A, Rakhmankulova, et al. "Association Between Clinical and Pathological Factors and Risk of Radioiodine Refractory in Patients with Differentiated Thyroid Carcinoma." Frontiers in Endocrinology, vol. 17, 2026, p. 1709736, https://doi.org/10.3389/fendo.2026.1709736.